Modulating nitric oxide synthesis: another contender enters the ring.
Kissoon
N
N
D000818:Animals; D016470:Bacteremia / Q000188:drug therapy / Q000276:immunology / Q000503:physiopathology*; D002116:Calcitonin / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D015971:Gene Expression Regulation, Enzymologic / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D006801:Humans; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000187:drug effects / Q000276:immunology / Q000502:physiology*; D052247:Nitric Oxide Synthase Type II; D011498:Protein Precursors / Q000276:immunology / Q000494:pharmacology / Q000502:physiology*; D051381:Rats
D011498:Protein Precursors; D009569:Nitric Oxide; D002116:Calcitonin; C496319:NOS2 protein, human; D019001:Nitric Oxide Synthase; D052247:Nitric Oxide Synthase Type II; C496318:Nos2 protein, rat